Clinical Trial Update: A Study of LY3841136 in Overweight and Obese Participants [Phase 1]

View source ↗

Summary

Phase 1 study of LY3841136 in overweight and obese participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• LY3841136

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 1 | Status: COMPLETED